Martis Capital Recognized for Contributions to Clinical Trials Market
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
Nina Leinman
https://secure.gravatar.com/avatar/c9e7080ca6fa5b11ac5325326ecc738b?s=96&d=mm&r=g
News
Martis Capital recognized as a Top 50 PE firm in the Middle Market for third consecutive year
https://www.martiscapital.com/wp-content/uploads/2022/01/TOP50PE2022_Blue_web.png
448
486
Nina Leinman
https://secure.gravatar.com/avatar/c9e7080ca6fa5b11ac5325326ecc738b?s=96&d=mm&r=g
Martis Capital recognized as a Top 50 PE firm in the Middle Market for third consecutive year
Martis Capital Announces Recent Promotions
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
Nina Leinman
https://secure.gravatar.com/avatar/c9e7080ca6fa5b11ac5325326ecc738b?s=96&d=mm&r=g
Martis Capital Announces Recent Promotions
Martis Capital and Lorient Capital Launch Rise Health
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
Nina Leinman
https://secure.gravatar.com/avatar/c9e7080ca6fa5b11ac5325326ecc738b?s=96&d=mm&r=g
Martis Capital and Lorient Capital Launch Rise Health
Finding Attractive Investment Opportunities Across Target Themes
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Finding Attractive Investment Opportunities Across Target Themes
Martis Capital Named in Inc.’s 2022 List of Founder-Friendly Investors
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital Named in Inc.’s 2022 List of Founder-Friendly Investors
Martis Capital Announces Investment in Alcanza Clinical Research
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital Announces Investment in Alcanza Clinical Research
Martis Capital welcomes new Senior Associate and Associate to the investment team
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital welcomes new Senior Associate and Associate to the investment team
Martis Capital recognized as a Top 50 PE firm in the Middle Market for 2022
https://www.martiscapital.com/wp-content/uploads/2022/01/TOP50PE2022_Blue_web.png
448
486
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital recognized as a Top 50 PE firm in the Middle Market for 2022
Martis Capital Announces Investment Team Promotions
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital Announces Investment Team Promotions
Martis Capital completes a majority recapitalization of Lighthouse Lab Services
https://www.martiscapital.com/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g
Martis Capital completes a majority recapitalization of Lighthouse Lab Services
Martis Capital Named in Inc.’s 2021 List of Founder-Friendly Investors
https://www.martiscapital.com/wp-content/uploads/2021/10/Inc_Founder-Friendly_Logo_2021.png
983
982
kari.sharp@gmail.com
https://secure.gravatar.com/avatar/ad1ca5fb0ac61bc75fee91545fa9a612?s=96&d=mm&r=g